Elevai Labs Inc (ELAB): Price Target Chart

Corporate company logo of Elevai Labs Inc (ELAB)

Elevai Labs Inc. (ELAB) production capacities for complex topical agents are operating on schedule, while the modernization of sterile zones will enable increased output volumes for new series. However, the business faces demand volatility in the luxury segment and regulatory pressure, which keeps the metric at 0.00. This historical price chart reflects the dynamics of a company developing stem cell-based regenerative products for aesthetic medicine.

Analyst Consensus Forecast: elevaiskincare.com (ELAB) for 02/21/2024 - 11/11/2026

Analytical breakdowns for Elevai Skincare (ELAB)

- current quotes and average value forecast:
Market Price elevaiskincare.com|ELAB - Price Target Chart
- stock exchange capitalization data:
Market Value Elevai Skincare|ELAB - Enterprise Value
- issuer book value statistics:
Book Value per Share Elevai Labs|ELAB - Book Capitalization|Market Value to Book Value Ratio elevaiskincare.com|ELAB - Aggregate Company Assets
- debt obligations and liquidity statistics:
Aggregate Debt to Equity Elevai Labs Inc.|ELAB - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Elevai Corp|ELAB - Company Aggregate Debts|Debts to Book Capitalization Elevai Skincare|ELAB - Company Long-Term Debt|Company Short-Term Loans and Borrowings Elevai Labs|Quick Liquidity Indicator elevaiskincare.com
- company profitability and valuation multiples indicators:
ELAB - Net Profit|Projected Future Earnings Elevai Labs Inc.|ELAB - Price to Earnings Ratio|Future Price to Earnings Multiple Elevai Labs Inc|ELAB - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Elevai Skincare|ELAB - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Elevai Labs|ELAB - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months elevaiskincare.com|ELAB - Earnings per share growth in current year|Projected earnings per share growth rate for next year Elevai Labs Inc.
General company analysis:ELAB elevaiskincare.com
Flagship merchandise of Elevai Corp

The average target price aggregates leading analysts' valuations of an asset's fair value, allowing investors to track institutional trends and determine the capital's margin of safety. The current consensus price target reflects market confidence in the commercialization of exosomes by Elevai Labs Inc. (ELAB), where growth in this metric correlates directly with the proven efficacy of the products and the scaling of orders from aesthetic medicine clinics.

Competitors of Elevai Labs Inc.

KRYS - Average Forecast Price|Price Target Chart Apogee Therapeutics, Inc. APGE|Arcutis - Price Target Chart|Vericel Corp. - Analyst Consensus Forecast|ORKA - Analyst Consensus Forecast|SMTI: Analyst Consensus Forecast|DBVT (DBV Technologies) - Price Target Chart|Price Target Chart Solesence Beauty|Journey Medical Corp. - Forecast Levels Chart|Analyst Consensus Forecast FBRX|EMPG (Empro Corporation) - Fair Value Consensus|Analyst Consensus Forecast SLGL (Sol-Gel Technologies)|Analyst Consensus Forecast AXIL Brands Inc AXIL|MDCX - Price Target Chart|Fair Value Consensus VRCA (Verrica Pharmaceuticals)|hoththerapeutics.com (HOTH) - Price Target Chart|Consensus Target Biofrontera|VYNE (VYNE Therapeutics, Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast Sonoma Pharma|Consensus Target QNRX (Quoin Pharmaceuticals)|AZTR (Azitra Inc) - Fair Value Consensus|Price Target Chart Dermata DRMA|Analyst Median Target Revance Therapeutics Inc (RVNC)